skip to content

Yusuf Hamied Department of Chemistry

 

Professor of Chemical Biology

Gonçalo Bernardes is a Professor of Chemical Biology & a Fellow of Trinity Hall College, Cambridge.

What we do

Nature has its own machinery for modifying the structure of proteins. In our research, we’re attempting to mimic this machinery to gain significant therapeutic benefits. We’re engineering chemical reactions that enable us to modify proteins while allowing to choose the precise location in the protein’s structure where we want to install these modifications.

This work has a whole range of applications. For example, we’re currently developing ways of selectively labelling proteins in living cells: this can help us monitor the proteins associated with particular diseases without interfering either with the protein’s structure, function, activity and location or upsetting the cell’s normal functions. Another important potential application for this work is linking cytotoxic drug molecules (molecules that are poisonous to cells) to antibodies and then using the antibody to deliver the drug in a very targeted way to the diseased tissue. This could improve the effectiveness of cancer treatments and reduce their side effects.

These are two examples from among our lines of research that use site-selective and bioorthogonal chemistry to address challenges in biology and medicine. We hope our methods may in future be used in laboratories around the world to help develop new drugs with improved effectiveness and reduced side-effects for some of the most common diseases such as cancer.

Funding

We are funded by the Royal Society, by UKRI (EPSRC) and by the European Commission (Marie Sklodowska Curie actions & European Research Council)

For further information on our research and for opportunities, please check our research group website.

Watch Professor Bernardes discuss his research

Take a tour of the Bernardes Lab

Publications

Carbon‐Monoxide‐Releasing Molecules for the Delivery of Therapeutic CO In Vivo
S García-Gallego, GJL Bernardes
– Angew Chem Int Ed Engl
(2014)
53,
9712
A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors.
N Krall, F Pretto, W Decurtins, GJL Bernardes, CT Supuran, D Neri
– Angew Chem Int Ed Engl
(2014)
53,
4231
Curative properties of noninternalizing antibody-drug conjugates based on maytansinoids.
E Perrino, M Steiner, N Krall, GJL Bernardes, F Pretto, G Casi, D Neri
– Cancer Research
(2014)
74,
2569
Rationally designed short polyisoprenol-linked PglB substrates for engineered polypeptide and protein N-glycosylation
F Liu, B Vijayakrishnan, A Faridmoayer, TA Taylor, TB Parsons, GJL Bernardes, M Kowarik, BG Davis
– Journal of the American Chemical Society
(2014)
136,
566
Rationally Designed Short Polyisoprenol-Linked PglB Substrates for Engineered Polypeptide and Protein N-Glycosylation
F Liu, B Vijayakrishnan, A Faridmoayer, TA Taylor, TB Parsons, GJL Bernardes, M Kowarik, BG Davis
– J Am Chem Soc
(2013)
136,
566
Protein micro- and nano-capsules for biomedical applications
U Shimanovich, GJL Bernardes, TPJ Knowles, A Cavaco-Paulo
– Chemical Society reviews
(2013)
43,
1361
Highlights from the 48th EUCHEM conference on stereochemistry, Bürgenstock, Switzerland, May 2013
GJL Bernardes
– Chem Commun (Camb)
(2013)
49,
8578
Site-specific chemical modification of antibody fragments using traceless cleavable linkers
GJL Bernardes, M Steiner, I Hartmann, D Neri, G Casi
– Nat Protoc
(2013)
8,
2079
Synthetically defined glycoprotein vaccines: current status and future directions
R Adamo, A Nilo, B Castagner, O Boutureira, F Berti, GJL Bernardes
– Chemical Science
(2013)
4,
2995
Chemoselective transformations for bioimaging and targeted therapeutics
GJL Bernardes
– EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
(2013)
42,
S55
  • <
  • 22 of 26
  • >

Research Group

Research Interest Groups

Telephone number

01223 336305

Email address

gb453@cam.ac.uk

College

Trinity Hall